[
1. McCrindle BW, Rowley CAH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E. Co-Chair Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease A Scientific Statement for Health Professionals From the American Heart Association. 29.03.3017; AHA JOURNALS; https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000000484. Accessed on 29.09.2021.
]Search in Google Scholar
[
2. Rowley AH, Baker SC, Shulman ST, Garcia FL, Fox LM, Kos IM, Crawford SE, Russo PA, Hammadeh R, Takahashi K, Orenstein JM. RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease.PLoS One. 2008;3:e1582. doi: 10.1371/journal.pone.0001582.CrossrefMedlineGoogle Scholar.10.1371/journal.pone.0001582
]Search in Google Scholar
[
3. Rowley AH, Baker SC, Shulman ST, Rand KH, Tretiakova MS, Perlman EJ, Garcia FL, Tajuddin NF, Fox LM, Huang JH, Ralphe JC, Takahashi K, Flatow J, Lin S, Kalelkar MB, Soriano B, Orenstein JM. Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a “new” virus associated with Kawasaki disease.J Infect Dis. 2011;203:1021–1030. doi: 10.1093/infdis/jiq136.CrossrefMedlineGoogle Scholar.10.1093/infdis/jiq136
]Search in Google Scholar
[
4. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.Circulation. 2004;110:2747–2771. doi: 10.1161/01.CIR.0000145143.19711.78.LinkGoogle Scholar.10.1161/01.CIR.0000145143.19711.78
]Search in Google Scholar
[
5. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC, Watson K, Wilson PW. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published corrections appear in Circulation. 2014;129(suppl 2):S46– S48 and Circulation. 2015;132:e396].Circulation.2014;129(suppl2):S1.45.doi:10.1161/01.cir.0000437738.63853.7a.LinkGoogle Scholar.10.1161/01.cir.0000437738.63853.7a
]Search in Google Scholar
